myriad genetics stock analysis

Learn about Myriad Genetics Inc MYDXDUS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and other stock information to. Myriad Genetics Stock Prediction.

Monitoring Myriad Genetics Nasdaq Mygn Seeking Alpha

The renowned molecular diagnostic company has a market.

. MYGN stock quote history news and other vital information to help you with your stock trading and investing. Try Out Our All-In-One Web-Based Platform For Modern Advisors. Ad Get the Inside Access Traders Are Using to Profit More and Win Bigger.

At the same time however the long-term average holds a general sell signal. Some negative signals were issued as well and these may have some influence on the near short-term development. MYGN stock analysis from Seeking Alphas top analysts.

InvestorsObserver gives Myriad Genetics Inc MYGN an overall rank of 42 which is below average. MYGN reported adjusted loss per share of 2 cents for the third quarter of 2021 versus the Zacks Consensus Estimate of earnin. Find the latest Myriad Genetics Inc.

Myriad Genetics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stocks chart. Investors eyeing a purchase of Myriad Genetics Inc. MYGN stock including valuation metrics financial numbers share information and more.

The Company primarily provides testing and collaborative development of testing that is designed to assess an individualâs risk for developing the disease later in life identify a patientâs likelihood of responding to drug therapy and guide a patientâs. Ad Investment Analysis Software Designed For The Way You Work Built On Data And Research. The companys average rating score is 150 and is based on no buy ratings 1 hold rating and 1 sell rating.

Exclusive research and insights from bulls and bears. Myriad Genetics Inc. Detailed statistics for Myriad Genetics Inc.

Start Your Free Trial. According to analysts consensus price target of 2900 Myriad Genetics has a forecasted upside of 475 from its current price of 1966. The Myriad Genetics stock holds a buy signal from the short-term moving average.

Get the Free report today. Summary of all time highs changes and price drops for Myriad Genetics. In 2021 MYGNs revenue was 69060 million an increase of 814 compared to the previous years 63860 million.

Find the latest Myriad Genetics Inc. Is currently rated as a Zacks Rank 3 and we are expecting an inline return from the MYGN shares relative. Myriad Genetics Inc.

Learn about Myriad Genetics Inc MYGNXNAS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and other stock information to. Click to get this free report Vertex Pharmaceuticals Incorporated VRTX. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

28 Analysts Opinion. Ad Buy these 10 stocks to generate a reliable source of income. MYGN - Research and Analysis for MYRIAD GENETICS INC.

Since the longterm average is. - Hold Zacks proprietary data indicates that Myriad Genetics Inc. Losses were -2720 million -8637 less than in 2020.

March 9 2022 453 PM EST. Make Informed Trades Before Share Prices React. Myriad Genetics has received a consensus rating of Hold.

- USA Stock USD 2614 094 373 As of the 1st of April Myriad Genetics secures the risk adjusted performance of 0014889 and Mean Deviation of 252. Real time Myriad Genetics MYGN stock price quote stock graph news analysis. Boost your income in 2022 with these 10 high-yield stocks.

Find the latest analyst research for Myriad Genetics Inc. Profit With Faster Market News Research. Shares of genetic testing specialist Myriad Genetics MYGN 061 dropped more than 13 today after it disclosed through an SEC filing that it had received a subpoena from the Department of.

Is a genetic testing and precision medicine company. MYRIAD GENETICS INC. A rank of 42 means that 58 of stocks appear more favorable to our system.

A high-level overview of Myriad Genetics Inc. Free Stock Analysis Report Myriad Genetics Inc. Myriad MYGN doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Get prepared with the key expectations. MYGN stock but cautious about paying the going market price of 2609share might. Free Stock Analysis Report Moderna Inc.

The MYRIAD GENETICS stock analysis report makes it easy to digest most publicly released information about MYRIAD GENETICS and get updates on important government artifacts including earning estimates SEC corporate filings and announcements. Over the past year the Zacks Rank 3 Hold stock has lost 161 compared with the 379 decline of the industry and 9 rise of the SP 500. This is considered to be a good technical signal.

Mygn Myriad Genetics Stock Price

Myriad Genetics Planned Counsyl Buyout To Widen Portfolio